X

Login






Register | Recover password

Inlean uses cookies to deliver you the best possible web experience. By continuing, you agree that we may store and access cookies on your device. Click here to view our cookie policy.


Last news

News


Inlean wants to maintain a transparent and constructive dialogue with its customers and partners. This section provides news and information about the company and the industry in general.




PharmaProcess points to personalized medicine as the future trend

BX2LRe3IQAA5JsE

First edition of PharmaProcess Forum on pharmaceutical industry has targeted personalized medicine based on biotechnology, as a trend of the future, during the event last week at Fira Montjuïc in Barcelona.

   According to a statement, biotechnology has been one of the highlights of the forum, because the techniques of cell and molecular biology are key to the creation of new drugs based on genetic characteristics of each patient, explained the president of the Spanish Association of Pharmaceutical Industry, Beatriz Artalejo.

   Control of worldwide drugs counterfeit, especially on the Internet, is another major challenge that has been addressed in the conference, and the director of Spanish Agency of Medicines and Health Products, Belén Crespo, said that "between 7% and 10% of drugs circulating the Internet are fake" and that only ones who have passed all controls are sold in pharmacies.

   Papers have highlighted the importance of innovation to boost the sector , the president of the International Federation of Manufacturers and Associations, Eduardo Pisani, has been hailed as responsible for "saving lives on an epic scale."

BX5oLjzIIAAdXnI

   President of PharmaProcess organizing committee, Ton Capella was very pleased with the results of this first edition, which has exceeded initial expectations by bringing together more than 200 delegates, nearly 800 visitors, 55 speakers and 50 exhibitors.

894486_174969446038874_796688623_o

(source Europa Press)

Inlean stand at PharmaProcess Forum.

image_5

< Back to news